Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Liquid Biopsy Market to 2027 - Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country - Regional Analysis & Market Forecasts

Published by The Insight Partners Product code 954637
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Liquid Biopsy Market to 2027 - Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country - Regional Analysis & Market Forecasts
Published: August 14, 2020 Content info: 100 Pages
Description

Title:
North America Liquid Biopsy Market to 2027 - Regional Analysis and Forecasts by Product & Services (Equipment, Reagents & Kits and Services); Sample (Blood Based, Urine Based and Other samples); Circulating Biomarker (Circulating Tumor Cells (CTC), Exosomes and Free Nucleic Acid); Application (Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics and Other Applications); End User (Academic & Research Institutes, Hospitals, Reference Laboratories and Other End Users); and, Country - Regional Analysis and Market Forecasts by Product & Services, Sample, Circulating Biomarker, Application and End User .

North America, the liquid biopsy market, is anticipated to reach US$ 3,531.44 Mn in 2027 from US$ 1,651.23 Mn in 2019. The market is projected to grow with a CAGR of 10.1% from 2019-2027.

The liquid biopsy market is growing primarily due to the increasing prevalence of cancer. Restraining factors, such as low sensitivity of liquid biopsy, is likely to damage the growth of the market in the coming years. On the other hand, increasing liquid biopsy due to growing application and advancements is expected to have a positive impact on the growth of the North American liquid biopsy market in the coming years.

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

Liquid biopsy is a non-invasive diagnostic test that identifies various types of cancer. The increasing prevalence of cancer among population is leading to the growth of liquid biopsy market across the world. For instance, in Canada, cancer is the leading cause of death among population and it is witnessed to be a second-leading cause after heart diseases in the US. As per the American Cancer Society, Inc, approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in Northern America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancers remains leading in females. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. Moreover, rapid change in lifestyle and consumption of alcohol and tobacco products are the factors increasing the incidences of cancer among the population. The largest potential market for liquid biopsy is a screening tool and testing the general asymptomatic population for different types of cancer.

Exosome Diagnostics Inc., Thermo Fisher Scientific Inc. and Bio-Rad Laboratories Inc. are among the major companies manufacturing liquid biopsy testing products to detect cancer. Therefore, increasing prevalence of cancer across the world is expected to drive the growth of the global liquid biopsy market during the forecast period.

In 2019, the reagents & kits segment accounted for the largest market share in the North American liquid biopsy market based on the product & services, and the similar segment is estimated to mark the highest CAGR in the market during the forecast period, owing to the availability of complete set of kits for liquid biopsy.

Moreover, in the United States, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Furthermore, the pandemic spread is also preventing the clinical trials, drug development, and diagnostic industry in the US. For instance, California-based Lucence Diagnostics Pte Ltd., who develops liquid biopsy and has a known player in this industry, has been diverted now to manufacture kits for COVID-19.

Some of the significant primary and secondary sources for liquid biopsy included in the report are American Cancer Society (ACR), Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF), and among others.

Reasons to Buy

To understand the liquid biopsy market landscape and identify market segments that are most likely to guarantee a strong return

Stay ahead of the race by comprehending the ever-changing competitive landscape for liquid biopsy market

Efficiently plan M&A and partnership deals in liquid biopsy market by identifying market segments with the most promising probable sales

Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form liquid biopsy market

Obtain market revenue forecast for market by various segments from 2018-2027 in North America region.

Table of Contents
Product Code: TIPRE00013010

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Liquid Biopsy Market - By Product & Service
    • 1.3.2 North America Liquid Biopsy Market - By Sample
    • 1.3.3 North America Liquid Biopsy Market - By Circulating Biomarker
    • 1.3.4 North America Liquid Biopsy Market - By Application
    • 1.3.5 North America Liquid Biopsy Market - By End User
    • 1.3.6 North America Liquid Biopsy Market - By Country

2. North America Liquid Biopsy Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Liquid Biopsy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America Liquid Biopsy Market - North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Liquid Biopsy - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Cancer
  • 5.2 Key Restraints
    • 5.2.1 Low Sensitivity of Liquid Biopsy
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Liquid Biopsy Due to Growing Application and Advancements
  • 5.4 Future Trends
    • 5.4.1 Consistent Launch of New Products
  • 5.5 Impact Analysis

6. Liquid Biopsy Market - North America Analysis

  • 6.1 North America Liquid Biopsy Market Revenue Forecasts and Analysis

7. Liquid Biopsy Market Analysis - By Product & Services

  • 7.1 Overview
  • 7.2 Liquid Biopsy Market Revenue Share, by Product& Service (2019 and 2027)
  • 7.3 Equipment
    • 7.3.1 Overview
  • 7.4 Equipment: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Reagents & Kits
    • 7.5.1 Overview
    • 7.5.2 Reagents & Kits: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Services
    • 7.6.1 Overview
    • 7.6.2 Services: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

8. Liquid Biopsy Market Analysis - By Sample

  • 8.1 Overview
  • 8.2 Liquid Biopsy Market, by Sample, 2019 and 2027 (%)
  • 8.3 Blood Based
    • 8.3.1 Overview
    • 8.3.2 Blood Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Urine Based
    • 8.4.1 Overview
    • 8.4.2 Urine Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Other Samples
    • 8.5.1 Overview
  • 8.6 Other Samples: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

9. Liquid Biopsy Market Analysis - By Circulating Biomarker

  • 9.1 Overview
  • 9.2 Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)
  • 9.3 Circulating Tumor Cells (CTC)
    • 9.3.1 Overview
    • 9.3.2 Circulating Tumor Cell (CTC): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Exosomes
    • 9.4.1 Overview
    • 9.4.2 Exosomes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Free Nucleic Acid
    • 9.5.1 Overview
  • 9.6 Free Nucleic Acid: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

10. Liquid Biopsy Market Analysis - By Application

  • 10.1 Overview
  • 10.2 Liquid Biopsy Market, by Application, 2019 and 2027 (%)
  • 10.3 Non-invasive Prenatal Testing (NIPT)
    • 10.3.1 Overview
    • 10.3.2 Noninvasive prenatal testing (NIPT): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Oncology
    • 10.4.1 Overview
    • 10.4.2 Oncology: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.5 Transplant Diagnostics
    • 10.5.1 Overview
    • 10.5.2 Transplant Diagnostics: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.6 Other Applications
    • 10.6.1 Overview
  • 10.7 Other applications: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

11. Liquid Biopsy Market Analysis - By End User

  • 11.1 Overview
  • 11.2 Liquid Biopsy Market, by End-User, 2019 and 2027 (%)
  • 11.3 Academic & Research Institutes
    • 11.3.1 Overview
    • 11.3.2 Academic & Research Institutes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.4 Hospitals
    • 11.4.1 Overview
    • 11.4.2 Hospitals: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.5 Reference Laboratories
    • 11.5.1 Overview
  • 11.6 Reference Laboratories: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.7 Other End Users
    • 11.7.1 Overview
  • 11.8 Other End Users: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

12. Liquid Biopsy Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 12.1 North America Liquid Biopsy Market Revenue and Forecasts To 2027
    • 12.1.1 Overview
    • 12.1.2 North America: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
    • 12.1.3 North America: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
    • 12.1.4 North America: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
    • 12.1.5 North America: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
    • 12.1.6 North America: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
    • 12.1.7 North America: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.8 North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)
    • 12.1.9 US: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.1 US: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.2 US: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.9.3 US: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.9.4 US: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.9.5 US: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.9.6 US: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.10 Canada: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.1 Canada: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.2 Canada: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.10.3 Canada: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.10.4 Canada: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.10.5 Canada: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.10.6 Canada: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.11 Mexico: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.11.1 Mexico: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.11.2 Mexico: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.11.3 Mexico: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.11.4 Mexico: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.11.5 Mexico: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.11.6 Mexico: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)

13. Impact of COVID-19 Pandemic on Global Liquid Biopsy Market

  • 13.1 North America: Impact Assessment of COVID-19 Pandemic

14. Company Profiles

  • 14.1 Thermo Fisher Scientific Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Bio-Rad Laboratories Inc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Exact Sciences Corporation
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 ey Developments
  • 14.4 Biocept, Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Inivata Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Liquid Biopsy Market, by Product & Service- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Estimated Number of New Cancer Cases and Deaths, US, 2020
  • Table 7. US Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 10. US Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. US Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Canada Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Canada Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Canada Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Canada Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Mexico Incidence, Mortality and Prevalence by cancer site in 2018
  • Table 18. Mexico Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Mexico Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Mexico Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Mexico Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Mexico Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 1. Glossary of Terms, North America Liquid Biopsy Market

List Of Figures

  • Figure 1. Liquid Biopsy Market Segmentation
  • Figure 2. North America Liquid Biopsy Market Overview
  • Figure 3. Reagents & Kits Segment Held Largest Share Of Product & Services Segment in Liquid Biopsy Market
  • Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. North America Liquid Biopsy Market- Leading Country Markets (US$ Mn)
  • Figure 7. North America Liquid Biopsy Market - North America PEST Analysis
  • Figure 8. Liquid Biopsy Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Liquid Biopsy Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 10. Liquid Biopsy Market Revenue Share, by Product & Service (2019 and 2027)
  • Figure 11. Equipment: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 12. Reagents & Kits: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Services: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 14. Liquid Biopsy Market, by Sample, 2019 and 2027 (%)
  • Figure 15. Blood Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Urine Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Other Samples: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)
  • Figure 19. Circulating Tumor Cell (CTC): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Exosomes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Free Nucleic Acid: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Liquid Biopsy Market, by Application, 2019 and 2027 (%)
  • Figure 23. Noninvasive prenatal testing (NIPT): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Oncology: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Transplant Diagnostics: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Other applications: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Liquid Biopsy Market, by End-User, 2019 and 2027 (%)
  • Figure 28. Academic & Research Institutes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Hospitals: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Reference Laboratories: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Other End Users: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. North America: Liquid Biopsy Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. North America Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)
  • Figure 34. North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)
  • Figure 35. US: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Canada: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Mexico: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Impact of COVID-19 Pandemic In North American Country Markets
Back to Top